NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Monday reported a loss of $60.7 million in its third quarter.
The New York-based company said it had a loss of 70 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 74 cents per share.
The biopharmaceutical company posted revenue of $45.9 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $48.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
